Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen-Resistant Prostatic Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06520345
What this trial is testing

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 520
Testing effectiveness (Phase 2)Ended earlyNCT01020305
What this trial is testing

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerProstatic NeoplasmsCastrate-resistant Prostate Cancer (CRPC)+3 more
Sandy Srinivas 5
Very early researchLooking for participantsNCT05802121
What this trial is testing

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Who this might be right for
Prostate CancerMetabolic SyndromeObesity+4 more
Western University 30
Not applicableStudy completedNCT01383863
What this trial is testing

A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Cancer
Ipsen 180
Testing effectiveness (Phase 2)Study completedNCT05171387
What this trial is testing

Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Bayer 78
Testing effectiveness (Phase 2)Study completedNCT05848011
What this trial is testing

Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Androgen-Independent Prostatic CancerAndrogen-Independent Prostatic NeoplasmsProstate Cancer Recurrent+6 more
MacroGenics 154
Not applicableWithdrawnNCT01275651
What this trial is testing

Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)WithdrawnNCT05191017
What this trial is testing

Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC

Who this might be right for
Prostate CancerProstatic CancerCancer of Prostate+5 more
Nuvation Bio Inc.
Not applicableStudy completedNCT01284608
What this trial is testing

Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)

Who this might be right for
Prostatic Cancer
AstraZeneca 197
Testing effectiveness (Phase 2)WithdrawnNCT04995978
What this trial is testing

Insulin Resistance and Androgen Deprivation Therapy

Who this might be right for
Prostate CancerInsulin Resistance
St. Louis University
Large-scale testing (Phase 3)Looking for participantsNCT07723248
What this trial is testing

Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
ORIC Pharmaceuticals 600
Not applicableStudy completedNCT01516866
What this trial is testing

Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 58
Large-scale testing (Phase 3)Ended earlyNCT03031821
What this trial is testing

Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome

Who this might be right for
Prostate CancerMetabolic Syndrome
Canadian Urologic Oncology Group 166
Large-scale testing (Phase 3)Ended earlyNCT02438007
What this trial is testing

Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC

Who this might be right for
Prostate Cancer
LTN PHARMACEUTICALS, INC. 953
Large-scale testing (Phase 3)UnknownNCT04026230
What this trial is testing

Impact of Atorvastatin on Prostate Cancer Progression During ADT

Who this might be right for
Metastatic Prostate CancerRecurrent Prostate Cancer
Tampere University Hospital 400
Very early researchStudy completedNCT03734653
What this trial is testing

Testosterone Therapy in Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-Resistant Prostate Cancer
University of Colorado, Denver 30
Early research (Phase 1)Ended earlyNCT02500901
What this trial is testing

Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)

Who this might be right for
Metastatic Prostate Cancer
Paul Mathew, MD 2
Not applicableLooking for participantsNCT07677254
What this trial is testing

Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Novartis Pharmaceuticals 17,111
Not applicableUnknownNCT05773183
What this trial is testing

Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men

Who this might be right for
Hypogonadism, MaleTestosterone DeficiencyProstate Cancer+8 more
Royal College of Surgeons, Ireland 60
Early research (Phase 1)Active Not RecruitingNCT03523442
What this trial is testing

Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 19
Next Page